Blueshift Asset Management, LLC Ptc Therapeutics, Inc. Transaction History

Blueshift Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$40.4 - $59.1 $223,048 - $326,291	5,521 New	5,521 $224,000
Q1 2022 May 12, 2022	SELL	$33.33 - $44.6 $168,183 - $225,051	-5,046 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.36 - $41.86 $178,426 - $211,225	5,046 New	5,046 $201,000
Q2 2021 Aug 13, 2021	SELL	$37.95 - $49.37 $321,360 - $418,065	-8,468 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$46.8 - $68.92 $38,750 - $57,065	828 Added 10.84%	8,468 $401,000
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $366,414 - $516,769	7,640 New	7,640 $466,000
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $218,354 - $339,324	-6,777 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$33.82 - $48.17 $229,198 - $326,448	6,777 New	6,777 $229,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.